NFE2L2 and Alzheimer disease: In this context, the nuclear factor-erythroid- 2-related factor 2 (NRF2) has been identified as a potential therapeutic target in AD, as this factor regulates the expression of antioxidant response genes and modulates mitochondrial function and biogenesis [10].